mild cognitive impairment
Biochemical signature predicts progression to Alzheimer’s disease
A study led by Research Professor Matej Oreič from VTT Technical Research Centre of Finland suggests that Alzheimer’s disease is preceded by a molecular signature indicative of hypoxia and up-regulated pentose phosphate pathway. This indicator c…
Financial planning a key but neglected component of Alzheimer’s care, say researchers
Patients newly diagnosed with Alzheimer’s disease or other dementias, and their families, need better guidance from their physicians on how to plan for the patient’s progressive loss of ability to handle finances, according to a study led by a physi…
Walking slows progression of Alzheimer’s
CHICAGO — Walking may slow cognitive decline in adults with mild cognitive impairment (MCI) and Alzheimer’s disease, as well as in healthy adults, according to a study presented today at the annual meeting of the Radiological Society of North Amer…
Focus on dementia
Alzheimer’s disease is not the only type of dementia. Two particular forms are dementia with Lewy bodies and Parkinson’s disease dementia. In both forms, the diagnosis is of vital importance because the treatment for these dementias differs from t…
Low testosterone linked to Alzheimer’s disease
ST. LOUIS — Low levels of the male sex hormone, testosterone, in older men is associated with the onset of Alzheimer’s disease, according to research by a team that includes a Saint Louis University scientist.
“Having low testosterone may ma…
MRI may predict continued decline in patients with mild cognitive impairment
OAK BROOK, Ill. — Using advanced MRI and an artificial intelligence technique, researchers in Geneva, Switzerland, have identified a method that may help identify which individuals with mild cognitive impairment (MCI) will continue to decline, acc…